Albert Bourla said Pfizer has discussed a fast-pass voucher with the White House during the JPMorgan Healthcare Conference.
Novo Nordisk A/S is back on the hunt for deals to boost its obesity portfolio after losing US biotech Metsera Inc. in a ...
Matthew Herper covers medical innovation — both its promise and its perils. Pfizer CEO Albert Bourla on Wednesday defended the development of Covid vaccinations, including Pfizer’s own, suggesting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback